Bioleap

Provider of computational fragment-based technology for drug discovery

placeTampa, Florida, United States calendar_todayFounded 2002 groups7 employees language bioleap.com

Registered entities

Innovation

6 patent families (5 granted) — focus: Mechanical engineering, Operations & transport, Chemistry & metallurgy, Emerging technologies; filing pace slowing. Cited 90 times.

YearFilings
20181
20195
20202
20212

Investor mix

3 investors on record; lead investors include Adams Capital Management.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon